Guangzhou, China– August , 2024 – Inc. “The EC approval of BAT2206 is anothersignificant accomplishment for Bio-Thera as...
查看详情Theclinical comparative study met its primary endpoint and showed similar efficacyand comparable safety profile in patie...
GUANGZHOU,China, October 24, 2023 -- Bio-Thera Solutions, Ltd (688177:SH), acommercial-stage biopharmaceutical company d...
TOFIDENCE is Bio-Thera’s first productapproved by USFDA.TOFIDENCE is the first monoclonal antibodydrug researched, devel...
